共 50 条
- [41] Continued progress in treatment options for multiple myeloma: From past to present and future - The Ning/He/Dagher et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (12): : 1511 - +
- [42] Pancreatic cancer: Incremental success in overcoming a major therapeutic challenge - The Senderowicz et al article reviewed: Advocate's perspective ONCOLOGY-NEW YORK, 2007, 21 (14): : 1712 - +
- [43] Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma - The Picozzi et al article reviewed ONCOLOGY-NEW YORK, 2001, 15 (10): : 1311 - +
- [44] The More Things Change, the More They Stay the Same THE MUSLIMANI ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (04): : 381 - 382
- [45] The Road to Romiplostim Approval and Beyond The Jamali/Lemery/Ayalew et al Article Reviewed ONCOLOGY-NEW YORK, 2009, 23 (08): : 709 - 715
- [46] Honing therapy for rectal cancer - The Willet/Duda/Czito et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (09): : 1065 - +
- [47] Intraoperative Radiotherapy for Breast Cancer: Deceptively Simple? THE ASH ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2013, 27 (02): : 122 - +
- [48] Innate Immune B Cells Gone Bad THE BETORNI ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (12): : 1149 - +
- [49] Anthracyclines survive targeted therapy - The Ning/He/Dagher et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (12): : 1516 - +
- [50] Diffuse Large B-Cell Lymphoma in the Very Elderly: The Case for Refining Our Clinical Trials THE LATTA ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2013, 27 (02): : 140 - +